3Grever MR, Kopecky K J, Coltman CA, et al. F1 udarabine monophosphate:A potentially useful agent in chronic lymphocytic leukemia[J]. Nouv Ret Fr Hematol, 1988,30 : 451-459.
4Bellosillo B, Villamor N, Colomer D, et al, In vitro evalution of fludarabine in combination With cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic lcukemia[J]. Blood, 1999, 94:2836-2843.
5McLaughlin P, Hagemeister FB, Swan F, et al. Phase I study of the combination of fludarabine, mitoxantrone, and dexam ethasone in low-grade lymphoma[J]. J Clin Oncol, 1996, 14:1262-1268.
6Kay N, Geyer S, Yaqoob I, et al. Thalidomide(Td) treatment in chronic lymphocytic leukemia(Chb):a North Central Cancer Treatment Group(NCCTG) study[J].Blood, 2003,102(abstr) : 5162.
7Chanan-KhanA, Miller KC, Takeshita K, et al. Results of-aphase I clinical trial of Thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL) [J]. Blood, 2005, 106 (10) : 3348-3352.
8Reed DN Jr,Vitale GC,Martin R,et al.Bileduct carcinoma:trends in treatment in the nineties.Am Surg,2000,66:711-714.
10O'Brien S,Kantarjian H,Beran M,et al.Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis derived prognostic model for response to treatment.Blood,1993,82:1695-1700.
